Scientific papers and presentations

Sharing our discoveries and developments in our tireless pursuit of breakthrough therapies

Newest first
Oldest first

Posters & Papers
Presentations

14/09/2024

ESMO 2024: A Phase 1/2a, Open-label, Dose-finding Trial to Evaluate Safety, Immunogenicity, and Anti-tumour Activity of VB10.16 in Combination with Pembrolizumab in Patients with Unresectable Recurrent or Metastatic HPV16-positive Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

20/06/2024

FOCIS 2024: Tolerogenic APC-targeted Vaccibody Vaccines Treat Disease in Mouse Models of Experimental Autoimmune Encephalomyelitis and Non-Obese Diabetes

11/06/2024

Nature Conferences: Cancer Immunotherapy – June 2024 | Targeted Delivery of Neoantigens to APCs using Vaccibodies Encoded in mRNA Results in Stronger and Broader T Cell Responses, and Improved Tumor Control

01/05/2024

7th International Neoantigen Summit – May 2024 | Optimizing RNA/DNA-Based Vaccine Design by Identifying Key Characteristics to Ensure Success of the Therapy

16/04/2024

AACR San Diego – 2024 | Targeting of neoantigen cancer vaccines to antigen presenting cells results in faster and broader T cell responses whether encoded in DNA or mRNA

Pages: 123456789